Glucose-Lowering Therapy for People With Cardiovascular Disease or Risk Factors for Cardiovascular Disease For people with type 2 diabetes and established ASCVD or indicators of high ASCVD risk, HF, or CKD, an SGLT2 inhibitor and/or GLP-1 RA with demonstrated cardiovascular benefit ( Table 9.2 ) is recommended independent of A1C, with or without metformin use, and in consideration of person-specific factors ( Fig
BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide derived from a gastric juice protein, extensively studied in cellular repair and angiogenesis research models
However, donation by athletes of plasma or plasma components by plasmapheresis by an official registered blood donation facility is no longer prohibited, allowing athletes to donate for humanitarian or other personal reasons
It is not a medicine, food supplement, or cosmetic ingredient
Nutraceutical intervention improves older adults cognitive functioning
Here are 5 emerging benefits of D-ribose supplements